Pain News and Research

Latest Pain News and Research

SAMHSA: Drug-related intentional poisonings result in 14,720 ED visits during 2009

Intentional poisoning refers to attempts to physically harm someone or render that person defenseless against crimes by deliberately getting them to ingest, inhale or in some other way take in a potentially harmful substance without their knowledge.

11 Nov 2011

Study reveals risk factors for temporomandibular disorders

Now, for the first time, researchers in the University at Buffalo School of Dental Medicine are publishing a comprehensive set of clinical characteristics that they say will lead to the ability to identify individuals at risk for developing the painful conditions. Their new clinical assessments will help researchers and clinicians better understand TMD and other pain conditions, so as to find ways to better manage and treat them.

11 Nov 2011

Insights into potential causes of temporomandibular joint disorders

New findings about painful jaw problems that plague millions of Americans are leading to a better understanding of pain disorders.

11 Nov 2011

Watson receives FDA approval for generic Kadian ANDA

Watson Pharmaceuticals, Inc. today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for morphine sulfate extended-release capsules USP, the generic equivalent of Actavis' Kadian.

11 Nov 2011

APMA encourages 'Knock Your Socks Off' foot care campaign for people with diabetes

American Podiatric Medical Association Encourages Hispanic Health Awareness with "Knock Your Socks Off" Foot Care Campaign, Promotes Regular Foot Exams by Podiatrist to End Diabetes Complications

10 Nov 2011

Brushing, flossing and antiseptic rinsing recommended for a healthy mouth

The makers of LISTERINE Antiseptic and award-winning singer and actress Kristin Chenoweth introduced today the newest video in the YOUR MOUTH HAS SOMETHING TO SAY series, designed to inspire Americans to redefine clean when it comes to their oral care routine.

10 Nov 2011

IRCM peptide chemist listed as inventor on two U.S. patents

In 2010, after more than 10 years of basic research, Dr. Peter W. Schiller, a world-renowned peptide chemist and Director of the Chemical Biology and Peptide research unit at the Institut de recherches cliniques de Montr-al (IRCM), and his international collaborators were the listed inventors on two U.S. patents awarded to the institute and covering different uses of a unique class of peptide compounds initially synthesized in Dr. Schiller's laboratory at the IRCM.

10 Nov 2011

Inadequate car seat support may trigger back pain

Inadequate car seat support may be responsible for triggering back pain, reports Edmunds.com, the premier online resource for automotive information. And while there are improvised ways to ease and prevent back discomfort - like purchasing an inflatable pillow or moldable seat supports - most new cars now offer technically advanced lumbar support adjustments.

10 Nov 2011

Rensselaer engineer receives $1.4M NIH grant to study new method to heal traumatic nerve damage

Injuries to the nervous system affect large numbers of people globally. Such injuries can result in loss of feeling or movement. With a new $1.4 million grant from the National Institutes of Health, Deanna Thompson, associate professor of biomedical engineering at Rensselaer Polytechnic Institute, will investigate a promising new method to heal traumatic nerve damage, using electrical stimulation to prime and pump neuronal growth.

10 Nov 2011

Positive results from Alkermes VIVITROL addiction study

Alkermes plc today presented positive results from a long-term study of VIVITROL (naltrexone for extended-release injectable suspension) at the 24th Annual U.S. Psychiatric and Mental Health Congress in Las Vegas, NV.

10 Nov 2011

State roundup: Alaska's dental problem; some Minn. health funding blocked

The need for dental care in rural Alaska is huge. According to a recent CDC report, the rate of cavities among rural Alaska Native children is four and a half times greater than the general population of U.S. children of the same age. ... But it's important to note the dental therapist program in Alaska is not without controversy.

10 Nov 2011

APS supports CDC's call for multifaceted approach to address prescription drug misuse

As reported by the U.S Centers for Disease Control, some 15,000 deaths occurred in the U.S. in 2008 from overdoses of prescription pain medications, and demand for treatment of prescription opioid addiction increased almost six fold between 1999 and 2009.

10 Nov 2011

Electrochemical sensor device can measure blood sugar levels from tears

Scientists are reporting development and successful laboratory testing of an electrochemical sensor device that has the potential to measure blood sugar levels from tears instead of blood - an advance that could save the world's 350 million diabetes patients the discomfort of pricking their fingers for droplets of blood used in traditional blood sugar tests.

10 Nov 2011

Medtronic initiates enrollment in Enlite Sensor study for diabetes

Medtronic, Inc. today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite Sensor, the company's latest innovation in continuous glucose monitoring (CGM) technology for people with diabetes.

From Medtronic 10 Nov 2011

New initiative to integrate and increase use of palliative care in ED

A new national initiative, IPAL-EM (Improving Palliative Care in Emergency Medicine) will integrate and increase the use of palliative care when seriously ill patients are admitted to the emergency department.

10 Nov 2011

Merck's NEXPLANON 68 mg now available in the U.S.

Merck today announced that NEXPLANON (etonogestrel implant) 68 mg, a long-acting, progestin-only single-rod hormonal contraceptive, is now available in the United States.

10 Nov 2011

PDI third quarter revenues increase 4% to $37.2 million

PDI, Inc., today reported financial and operational results for the third quarter ended September 30, 2011.

10 Nov 2011

ACADIA third quarter revenues decrease to $584,000

ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.

9 Nov 2011

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.

9 Nov 2011

NIH announces results from first large scale study on treatment of prescription opioid addiction

People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in yesterday's Archives of General Psychiatry and conducted by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

9 Nov 2011

Pain News and Research

Latest Pain News and Research

SAMHSA: Drug-related intentional poisonings result in 14,720 ED visits during 2009

Study reveals risk factors for temporomandibular disorders

Insights into potential causes of temporomandibular joint disorders

Watson receives FDA approval for generic Kadian ANDA

APMA encourages 'Knock Your Socks Off' foot care campaign for people with diabetes

Brushing, flossing and antiseptic rinsing recommended for a healthy mouth

IRCM peptide chemist listed as inventor on two U.S. patents

Inadequate car seat support may trigger back pain

Rensselaer engineer receives $1.4M NIH grant to study new method to heal traumatic nerve damage

Positive results from Alkermes VIVITROL addiction study

State roundup: Alaska's dental problem; some Minn. health funding blocked

APS supports CDC's call for multifaceted approach to address prescription drug misuse

Electrochemical sensor device can measure blood sugar levels from tears

Medtronic initiates enrollment in Enlite Sensor study for diabetes

New initiative to integrate and increase use of palliative care in ED

Merck's NEXPLANON 68 mg now available in the U.S.

PDI third quarter revenues increase 4% to $37.2 million

ACADIA third quarter revenues decrease to $584,000

Positive results from NeuroDerm's ND0611 Phase I/II study for advanced Parkinson's disease

NIH announces results from first large scale study on treatment of prescription opioid addiction

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in